GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Map2k1 | decreases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | CTD | Arsenic Trioxide results in decreased activity of MAP2K1 protein | PMID:11304686 | Map2k1 | decreases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | CTD | Arsenic Trioxide results in decreased phosphorylation of MAP2K1 protein | PMID:28454374 | Map2k1 | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | CTD | Arsenic Trioxide results in decreased phosphorylation of MAP2K1 protein | PMID:20592496 | Map2k1 | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | CTD | Arsenic Trioxide results in increased expression of MAP2K1 mRNA | PMID:22521957 | Map2k1 | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | CTD | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide promotes the reaction [Tretinoin results in increased phosphorylation of and results in increased activity of MAP2K1 protein]]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K1 protein | PMID:20615082 | |
Go Back to source page | Continue to Ontology report |